The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension

  • Angelo Tremblay
  • Jean-Philippe Chaput
  • Sonia Bérubé-Parent
  • Denis Prud’homme
  • Claude Leblanc
  • Natalie Alméras
  • Jean-Pierre Després
Clinical Trials



Topiramate (TPM) has been reported to reduce body weight beyond a placebo in the treatment of obese participants, but the effect of this agent on components of energy balance has not yet been established in humans. Thus, the aim of this study was to study the impact of TPM on food preferences, measures of satiety, food intake, resting metabolic rate (RMR), and 24-h energy expenditure.


The study design consisted of a 6-month, single-center, randomized, double-blind, parallel group, placebo-controlled trial with a 6-month open-label extension. The study included 68 sedentary men with abdominal obesity (waist circumference ≥100 cm), of between 25 and 55 years of age, with a dyslipidemic profile and a body mass index (BMI) ≥27 and ≤40 kg/m2.


Treatment with TPM produced significant changes in anthropometric variables and body composition compared with placebo. However, at the end of the 1-year study, the placebo/TPM group showed similar weight loss and reduction in body fatness compared with the TPM/TPM group. For instance, at the end of the 12-month intervention, mean percentage of body weight loss from baseline was about −5% in both groups (−4 kg fat loss). Topiramate treatment reduced energy intake, be it in the context of an ad libitum buffet-type meal or under free living conditions. The 24-h daily energy expenditure (DEE) assessed by whole-body indirect calorimetry adjusted for body weight and age was not altered by TPM treatment.


Topiramate treatment produced significantly greater weight loss than placebo and the majority of this loss was explained by a decrease in body fat stores. Most of the weight loss effect produced by TPM therapy was observed within a period of 6 months. Finally, TPM treatment had an impact on energy balance through a reduction in food intake that appears to have created an energy deficit of about 30,000–40,000 kcal compared with treatment with the placebo over 6 months.


Appetite Body composition Energy balance Food preferences Topiramate 


  1. 1.
    Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB (1999) Sibutramine produces dose-related weight loss. Obes Res 7:189–198PubMedGoogle Scholar
  2. 2.
    Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M (1998) Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 352:167–172PubMedCrossRefGoogle Scholar
  3. 3.
    Picard F, Deshaies Y, Lalonde J, Samson P, Richard D (2000) Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats. Obes Res 8:656–663PubMedGoogle Scholar
  4. 4.
    York DA, Singer L, Thomas S, Bray GA (2000) Effect of topiramate on body weight and body composition of Osborne-Mendel rats fed a high-fat diet: alterations in hormones, neuropeptide, and uncoupling-protein mRNAs. Nutrition 16:967–975PubMedCrossRefGoogle Scholar
  5. 5.
    Richard D, Picard F, Lemieux C, Lalonde J, Samson P, Deshaies Y (2002) The effects of topiramate and sex hormones on energy balance of male and female rats. Int J Obes Relat Metab Disord 26:344–353PubMedCrossRefGoogle Scholar
  6. 6.
    Richard D, Ferland J, Lalonde J, Samson P, Deshaies Y (2000) Influence of topiramate in the regulation of energy balance. Nutrition 16:961–966PubMedCrossRefGoogle Scholar
  7. 7.
    Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry BH, U.S. Topiramate Research Group (2003) A 6-month randomized, placebo-controlled, dose-ranging trial for weight loss in obesity. Obes Res 11:722–733PubMedGoogle Scholar
  8. 8.
    Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M, for the OBES-002 Study Group (2004) A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects. Int J Obes Relat Metab Disord 28:1399–1410PubMedCrossRefGoogle Scholar
  9. 9.
    Astrup A, Caterson I, Zelissen P, Guy-Grand B, Carruba M, Levy B, Sun X, Fitchet M, OBES-004 Study Group (2004) Topiramate: long-term maintenance of weight loss induced by low-calorie diet in obese subjects. Obes Res 12:1658–1669PubMedCrossRefGoogle Scholar
  10. 10.
    Airlie (VA) Consensus Conference (1988) Standardization of anthropometric measurements. Human Kinetics Publishers, Champaign, ILGoogle Scholar
  11. 11.
    Lohman TG (1988) Anthropometry and body composition. In: Lohman TG, Roche AF, Martorell R (eds) Anthropometric standardization reference manual. Human Kinetics, Champaign, ILGoogle Scholar
  12. 12.
    Behnke AR, Wilmore JH (1974) Evaluation and regulation of body build and composition. In: Behnke AR (eds) Evaluation and regulation of body build and composition. Englewood Cliffs, Prentice-Hall, NJ, pp 20–37Google Scholar
  13. 13.
    Meneely GR, Kaltreider NL (1949) Volume of the lung determined by helium dilution. J Clin Invest 28:129–139PubMedGoogle Scholar
  14. 14.
    Siri WE (1956) The gross composition of the body. Adv Biol Med Phys 4:239–280PubMedGoogle Scholar
  15. 15.
    Hill AJ, Blundell JE (1986) The effects of a high-protein or high-carbohydrate meal on subjective motivation to eat and food preferences. Nutr Behav 3:133–144Google Scholar
  16. 16.
    Doucet E, Imbeault P, St-Pierre S, Alméras N, Mauriège P, Richard D, Tremblay A (2000) Appetite after weight loss by energy restriction and low-fat diet-exercise follow-up. Int J Obes 24:906–914CrossRefGoogle Scholar
  17. 17.
    Arvaniti K, Richard D, Tremblay A (2000) Reproducibility of energy and macronutrient intake and related substrate oxidation rates in a buffet-type meal. Br J Nutr 83:489–495PubMedGoogle Scholar
  18. 18.
    Canadian Nutrient File (2005) Health and Welfare, CanadaGoogle Scholar
  19. 19.
    Tremblay A, Sévigny J, Leblanc C, Bouchard C (1983) The reproducibility of a three-day dietary record. Nutr Res 3:819–830CrossRefGoogle Scholar
  20. 20.
    Weir JB (1949) New method for calculating metabolic rate with special references to protein metabolism. J Physiol 109:1–9PubMedGoogle Scholar
  21. 21.
    Bouchard C (1985) Body-composition assessments in youth and adults. In: Roche E Jr (eds) Report of the Sixth ROSS Conference on Medical Research. Ross Laboratories, Colombus, OHGoogle Scholar
  22. 22.
    Frayn K (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628–634PubMedGoogle Scholar
  23. 23.
    White MD, Buemann B, Alméras N, Després JP, Bouchard C, Tremblay A (1996) Reproducibility of 24-h energy expenditure and macronutrient oxidation rates in a indirect calorimeter. J Appl Physiol 80:133–139PubMedGoogle Scholar
  24. 24.
    White MD, Bouchard G, Buemann B, Alméras N, Després JP, Bouchard C, Tremblay A (1997) Energy and macronutrient balances for humans in a whole body metabolic chamber without control of preceding diet and activity level. Int J Obesity 21:135–140CrossRefGoogle Scholar
  25. 25.
    Tremblay A, Poehlman ET, Després JP, Thériault G, Danforth E, Bouchard C (1997) Endurance training with constant energy intake in identical twins: changes over time in energy expenditure and related hormones. Metabolism 46:499–503PubMedCrossRefGoogle Scholar
  26. 26.
    Prud’homme D, Dumont M, Brochu M, Alméras N, Nadeau A, Després JP (1997) Beneficial effects of a 12-week fenfluramine treatment on the cardiovascular disease risk profile of visceral obese men. Int J Obes 21[Suppl 2]:S-65Google Scholar
  27. 27.
    Hins J, Sériès F, Alméras N, Tremblay A (2006) Relationship between severity of nocturnal desaturation and adaptative thermogenesis: preliminary data of apneic patients tested in a whole-body indirect calorimetry chamber. Int J Obes 30:574–577CrossRefGoogle Scholar
  28. 28.
    Doucet E, Imbeault P, St-Pierre S, Almeras N, Mauriège P, Després JP, Bouchard C, Tremblay A (2003) Greater than predicted decrease in energy expenditure during exercise after body weight loss in obese men. Clin Sci (Lond) 105:89–95CrossRefGoogle Scholar
  29. 29.
    Leibel RL, Rosenbaum M, Hirsch J (1995) Changes in energy expenditure resulting from altered body weight. N Engl J Med 332:621–628PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Angelo Tremblay
    • 1
  • Jean-Philippe Chaput
    • 1
  • Sonia Bérubé-Parent
    • 1
  • Denis Prud’homme
    • 2
  • Claude Leblanc
    • 1
  • Natalie Alméras
    • 3
  • Jean-Pierre Després
    • 4
    • 5
  1. 1.Division of Kinesiology (PEPS), Department of Social and Preventive MedicineLaval UniversityQuébecCanada
  2. 2.School of Human KineticsUniversity of OttawaOttawaCanada
  3. 3.Department of Food Sciences and NutritionLaval UniversityQuébecCanada
  4. 4.Lipid Research CenterCHUL Research CenterQuébecCanada
  5. 5.Quebec Heart InstituteQuébecCanada

Personalised recommendations